Self-Study HBV Lessons
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 5 Overview
When to Initiate HBV Treatment - 0%Topic 1
BackgroundActivities- 0%Topic 2
Goals of Therapy with Treatment of Chronic HBVActivities- 0%Topic 3
Factors Used to Determine Whether to Initiate TreatmentActivities- 0%Topic 4
Hepatitis B Treatment Guidance RecommendationsWhen to Initiate HBV Treatment Overview
About this Lesson
Last Updated: October 8th, 2024CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: February 15th, 2020CNE and CME Review: January 16th, 2023CNE and CME Expiration: January 15th, 2026 (2nd Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE2nd Edition
This is a substantial revision of the original Lesson. The previous edition was titled When to Initiate HBV Treatment and available until January 16th, 2023.Learning Objectives
- Describe primary goals of therapy for the treatment of chronic HBV infection
- Name three key factors to consider when initiating treatment for chronic HBV infection
- List the four phases of immune responses that characterize HBV infection
- Summarize key recommendations in major guidance documents regarding when to initiate HBV treatment
- Discuss the clinical circumstances that warrant antiviral therapy in persons with chronic HBV infection for whom therapy may not be indicated
Lesson Contributors
Authors
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
- 0%Topic 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
- HBV Medications
- Self-Study Modules CNE/CME
- HBV Epidemiology
- HBV Screening, Testing, and Diagnosis
- HBV Immunizations
- Initial Evaluation of Persons with Chronic Hepatitis B
- When to Initiate HBV Treatment
- Choosing an Initial HBV Treatment Regimen
- Monitoring Persons On and Off HBV Therapy
- Preventing HBV Perinatal Transmission
- Screening for Hepatocellular Carcinoma
- Occupational HBV Postexposure Prophylaxis
- Hepatitis B Reactivation in the Setting of Immunosuppression
Quick Reference
- HBV Epidemiology
- HBV Screening, Testing, and Diagnosis
- HBV Immunizations
- Initial Evaluation of Persons with Chronic Hepatitis B
- When to Initiate HBV Treatment
- Choosing an Initial HBV Treatment Regimen
- Monitoring Persons On and Off HBV Therapy
- Preventing HBV Perinatal Transmission
- Screening for Hepatocellular Carcinoma
- Occupational HBV Postexposure Prophylaxis
- Hepatitis B Reactivation in the Setting of Immunosuppression
- Clinical ChallengesHepatitis B Primary Care Guidance Master Bibliography
Contributors - Tools & Calculators
Copyright © 2024 Hepatitis B Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhbvc-master-8a67d9cc-2024-11-13-205626